Abata Therapeutics to Participate in the Guggenheim I&I Spotlight Series – Treg-Based Therapies
BOSTON–(BUSINESS WIRE)–Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with severe autoimmune and inflammatory diseases, today announced that Samantha Singer, M.S., M.B.A., president, and chief executive officer, and John Trzupek, M.B.A., Ph.D., chief operating officer of Abata will participate in a fireside chat … [Read more…]
